SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-128598
Filing Date
2023-12-22
Accepted
2023-12-22 09:05:24
Documents
12
Period of Report
2023-12-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333390d1_8k.htm   iXBRL 8-K 27458
  Complete submission text file 0001104659-23-128598.txt   201770

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sls-20231219.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20231219_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20231219_pre.xml EX-101.PRE 22378
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2333390d1_8k_htm.xml XML 3320
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 231507410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)